82 related articles for article (PubMed ID: 9354676)
1. A novel chromosomal translocation t(4; 14)(p16.3; q32) in multiple myeloma involves the fibroblast growth-factor receptor 3 gene.
Richelda R; Ronchetti D; Baldini L; Cro L; Viggiano L; Marzella R; Rocchi M; Otsuki T; Lombardi L; Maiolo AT; Neri A
Blood; 1997 Nov; 90(10):4062-70. PubMed ID: 9354676
[TBL] [Abstract][Full Text] [Related]
2. Frequent translocation t(4;14)(p16.3;q32.3) in multiple myeloma is associated with increased expression and activating mutations of fibroblast growth factor receptor 3.
Chesi M; Nardini E; Brents LA; Schröck E; Ried T; Kuehl WM; Bergsagel PL
Nat Genet; 1997 Jul; 16(3):260-4. PubMed ID: 9207791
[TBL] [Abstract][Full Text] [Related]
3. Ectopic expression of MAFB gene in human myeloma cells carrying (14;20)(q32;q11) chromosomal translocations.
Hanamura I; Iida S; Akano Y; Hayami Y; Kato M; Miura K; Harada S; Banno S; Wakita A; Kiyoi H; Naoe T; Shimizu S; Sonta SI; Nitta M; Taniwaki M; Ueda R
Jpn J Cancer Res; 2001 Jun; 92(6):638-44. PubMed ID: 11429052
[TBL] [Abstract][Full Text] [Related]
4. Frequent occurrence of CCND1 deregulation in patients with early stages of plasma cell dyscrasia.
Miura K; Iida S; Hanamura I; Kato M; Banno S; Ishida T; Kusumoto S; Takeuchi G; Miwa H; Nitta M; Inagaki H; Eimoto T; Nomura K; Taniwaki M; Ueda R
Cancer Sci; 2003 Apr; 94(4):350-4. PubMed ID: 12824903
[TBL] [Abstract][Full Text] [Related]
5. Observation and prediction of recurrent human translocations mediated by NAHR between nonhomologous chromosomes.
Ou Z; Stankiewicz P; Xia Z; Breman AM; Dawson B; Wiszniewska J; Szafranski P; Cooper ML; Rao M; Shao L; South ST; Coleman K; Fernhoff PM; Deray MJ; Rosengren S; Roeder ER; Enciso VB; Chinault AC; Patel A; Kang SH; Shaw CA; Lupski JR; Cheung SW
Genome Res; 2011 Jan; 21(1):33-46. PubMed ID: 21205869
[TBL] [Abstract][Full Text] [Related]
6.
Hui H; Fuller KA; Eresta Jaya L; Konishi Y; Ng TF; Frodsham R; Speight G; Yamada K; Clarke SE; Erber WN
J Clin Pathol; 2023 Nov; 76(11):763-769. PubMed ID: 36113967
[TBL] [Abstract][Full Text] [Related]
7. Conventional Cytogenetics and Interphase Fluorescence In Situ Hybridization Results in Multiple Myeloma: A Turkey Laboratory Analysis of 381 Cases.
Aydin C; Ulas T; Hangul C; Yucel OK; Iltar U; Salim O; Ekinci D; Berker Karauzum S
Indian J Hematol Blood Transfus; 2020 Apr; 36(2):284-291. PubMed ID: 32425379
[TBL] [Abstract][Full Text] [Related]
8. Immunoglobulin gene translocations in chronic lymphocytic leukemia: A report of 35 patients and review of the literature.
DE Braekeleer M; Tous C; Guéganic N; LE Bris MJ; Basinko A; Morel F; Douet-Guilbert N
Mol Clin Oncol; 2016 May; 4(5):682-694. PubMed ID: 27123263
[TBL] [Abstract][Full Text] [Related]
9. Myeloma immunoglobulin rearrangement and translocation detection through targeted capture sequencing.
Chow S; Kis O; Mulder DT; Danesh A; Bruce J; Wang TT; Reece D; Bhalis N; Neri P; Sabatini PJ; Keats J; Trudel S; Pugh TJ
Life Sci Alliance; 2023 Jan; 6(1):. PubMed ID: 36328595
[TBL] [Abstract][Full Text] [Related]
10. Identification of allelic relationship and translocation region among chromosomal translocation lines that leads to less-seed watermelon.
Jiao D; Zhao H; Sun H; Zhang J; Zhang H; Gong G; Anees M; Zhu H; Liu W; Xu Y
Hortic Res; 2024 May; 11(5):uhae087. PubMed ID: 38799123
[TBL] [Abstract][Full Text] [Related]
11. Alternative splicing in multiple myeloma is associated with the non-homologous end joining pathway.
Liu E; Becker N; Sudha P; Dong C; Liu Y; Keats J; Morgan G; Walker BA
Blood Cancer J; 2023 Jan; 13(1):16. PubMed ID: 36670103
[TBL] [Abstract][Full Text] [Related]
12. The biological and clinical impact of deletions before and after large chromosomal gains in multiple myeloma.
Cirrincione AM; Poos AM; Ziccheddu B; Kaddoura M; Baertsch MA; Maclachlan KH; Chojnacka M; Diamond BT; John L; Reichert P; Huhn S; Blaney P; Gagler DC; Rippe K; Zhang Y; Dogan A; Lesokhin AM; Davies FE; Goldschmidt H; Fenk R; Weisel KC; Mai EK; Korde N; Morgan GJ; Usmani SZ; Landgren O; Raab MS; Weinhold N; Maura F
Blood; 2024 May; ():. PubMed ID: 38728430
[TBL] [Abstract][Full Text] [Related]
13. Frequent dysregulation of the c-maf proto-oncogene at 16q23 by translocation to an Ig locus in multiple myeloma.
Chesi M; Bergsagel PL; Shonukan OO; Martelli ML; Brents LA; Chen T; Schröck E; Ried T; Kuehl WM
Blood; 1998 Jun; 91(12):4457-63. PubMed ID: 9616139
[TBL] [Abstract][Full Text] [Related]
14. Transcriptome analysis reveals molecular mechanisms of lymphocystis formation caused by lymphocystis disease virus infection in flounder (
Zhang H; Sheng X; Tang X; Xing J; Chi H; Zhan W
Front Immunol; 2023; 14():1268851. PubMed ID: 37868974
[TBL] [Abstract][Full Text] [Related]
15. Enhancing B-Cell Malignancies-On Repurposing Enhancer Activity towards Cancer.
Kasprzyk ME; Sura W; Dzikiewicz-Krawczyk A
Cancers (Basel); 2021 Jun; 13(13):. PubMed ID: 34210001
[TBL] [Abstract][Full Text] [Related]
16. Fibroblast growth factor receptors in cancer: genetic alterations, diagnostics, therapeutic targets and mechanisms of resistance.
Krook MA; Reeser JW; Ernst G; Barker H; Wilberding M; Li G; Chen HZ; Roychowdhury S
Br J Cancer; 2021 Mar; 124(5):880-892. PubMed ID: 33268819
[TBL] [Abstract][Full Text] [Related]
17. Transcriptional heterogeneity of clonal plasma cells and immune evasion in immunoglobulin light chain amyloidosis.
Wang Y; Xu L; Liu Y; Hu Y; Shi Q; Jin L; Yang L; Wang P; Zhang K; Huang X; Ge Q; Lu J
Int J Hematol; 2021 Feb; 113(2):231-242. PubMed ID: 33040275
[TBL] [Abstract][Full Text] [Related]
18. Serum fibroblast growth factor 19 serves as a potential novel biomarker for hepatocellular carcinoma.
Maeda T; Kanzaki H; Chiba T; Ao J; Kanayama K; Maruta S; Kusakabe Y; Saito T; Kobayashi K; Kiyono S; Nakamura M; Ogasawara S; Suzuki E; Ooka Y; Nakamoto S; Nakagawa R; Muroyama R; Kanda T; Maruyama H; Kato N
BMC Cancer; 2019 Nov; 19(1):1088. PubMed ID: 31718608
[TBL] [Abstract][Full Text] [Related]
19. Targeting FGFR overcomes EMT-mediated resistance in EGFR mutant non-small cell lung cancer.
Raoof S; Mulford IJ; Frisco-Cabanos H; Nangia V; Timonina D; Labrot E; Hafeez N; Bilton SJ; Drier Y; Ji F; Greenberg M; Williams A; Kattermann K; Damon L; Sovath S; Rakiec DP; Korn JM; Ruddy DA; Benes CH; Hammerman PS; Piotrowska Z; Sequist LV; Niederst MJ; Barretina J; Engelman JA; Hata AN
Oncogene; 2019 Sep; 38(37):6399-6413. PubMed ID: 31324888
[TBL] [Abstract][Full Text] [Related]
20. Fibroblast growth factor receptor signaling in pediatric B-cell precursor acute lymphoblastic leukemia.
Jerchel IS; Hoogkamer AQ; Ariës IM; Boer JM; Besselink NJM; Koudijs MJ; Pieters R; den Boer ML
Sci Rep; 2019 Feb; 9(1):1875. PubMed ID: 30755670
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
